Biosimulation involves the use of computer-based models to simulate biological processes, drug interactions, and various aspects of physiological systems. It is widely utilized in pharmaceutical research and development to predict the behavior of drugs, study disease mechanisms, and optimize treatment strategies.
Simulations Plus acquires Immunetrics: This strengthens Simulations Plus' quantitative systems pharmacology (QSP) expertise and expands its reach in oncology, immunology, and autoimmune diseases.
Certara partners with Infosys: This collaboration aims to integrate Certara's biosimulation software with Infosys' life sciences cloud platform, offering more accessible and scalable modeling solutions.
Thermo Fisher Scientific and Simulia collaborate: This partnership focuses on developing digital twins for bioreactors, allowing for real-time monitoring and optimization of biomanufacturing processes.
Certara unveils SimCyp Pediatric 5.0: This latest version of their popular pharmacokinetic (PK) simulation platform features an expanded pediatric database and new modeling capabilities for pediatric drug development.
Physiomics launches the Virtual Tumor Suite 5.0: This upgraded software offers improved tumor growth and treatment response prediction for personalized medicine applications.
Advanced Chemistry Labs introduces the NMRView® Exchange software: This innovative tool automates the analysis of biomolecular interactions using nuclear magnetic resonance (NMR) spectroscopy.
Biosimulation Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)